CTKB - Cytek Biosciences, Inc.
4.32
-0.260 -6.019%
Share volume: 556,843
Last Updated: 03-27-2026
Measuring And Control Equipment/Lab Analytical Instruments:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$4.58
-0.26
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-06-2024 | 11-06-2024 | 02-27-2025 | 05-08-2025 | 11-05-2025 | 02-26-2026 | |
| Total revenue | 44.860 M | 46.617 M | 51.500 M | 57.476 M | 41.457 M | 52.293 M | 62.141 M | |
| Cost of revenue | 21.847 M | 21.181 M | 22.495 M | 23.824 M | 21.300 M | 24.742 M | 29.256 M | |
| Gross profit | 23.013 M | 25.436 M | 29.005 M | 33.652 M | 20.157 M | 27.551 M | 32.885 M | |
| 10.53% | 14.03% | 16.02% | -40.10% | 36.68% | 19.36% | |||
| Operating expenses | 21.204 M | 21.695 M | 20.824 M | 18.792 M | 22.623 M | 25.077 M | 25.347 M | |
| Selling general and admin | 11.408 M | 11.694 M | 10.942 M | 9.069 M | 12.898 M | 16.121 M | 16.386 M | |
| Research and development | 9.796 M | 10.001 M | 9.882 M | 9.723 M | 9.725 M | 8.956 M | 8.961 M | |
| Total expenses | 33.747 M | 33.963 M | 33.253 M | 30.666 M | 35.132 M | 36.743 M | 38.478 M | |
| 0.64% | -2.09% | -7.78% | 14.56% | 4.59% | 4.72% | |||
| Operating income | -10.734 M | -8.527 M | -4.248 M | 2.986 M | -14.975 M | -9.192 M | -5.593 M | |
| Ebit | -9.911 M | -8.468 M | -1.157 M | 3.476 M | -11.483 M | -7.848 M | -5.336 M | |
| Pretax income | -8.993 M | -7.186 M | 157.000 K | 10.322 M | -11.266 M | -7.769 M | -4.031 M | |
| -20.09% | -102.18% | 6,474.52% | -209.15% | -31.04% | -48.11% | |||
| Income tax | -2.824 M | 3.248 M | -784.000 K | 680.000 K | 136.000 K | -2.291 M | 40.045 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -6.169 M | -10.434 M | 941.000 K | 9.642 M | -11.402 M | -5.478 M | -44.076 M | |
| -69.14% | 109.02% | 924.65% | -218.25% | 51.96% | -704.60% |